Nadela, Kriziah Mae O.

HRN: 09-08-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
CEFUROXIME 750MG (VIAL)
05/23/2022
05/30/2022
IV
550mg
Q8h
Dengue Fever With Warning Signs; Uti
Waiting Final Action 
01/26/2023
CEFUROXIME 750MG (VIAL)
01/26/2023
02/02/2023
IV
750 Mg
Q8
AGE With Mod DHN
Waiting Final Action 
01/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/26/2023
02/02/2023
IV
225mg
Q8
Amoebiasis
Waiting Final Action 
01/27/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/27/2023
02/02/2023
ORAL
12 Ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: